This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Treatment of Refractory Major Depression With Tramadol Monotherapy

Nathan Andrew Shapira, Marcia L. Verduin, and John D. DeGraw

Published: March 1, 2001

Article Abstract

Letter to the Editor

Sir: Recent reports describe treatment of patients with refractory major depression using augmentation with the µ-opiate agonists oxycodone and oxymorphone and the partial agonist buprenorphine. We report a patient with refractory major depression who responded to tramadol hydrochloride monotherapy.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 62

Quick Links: Pain , Somatic Symptoms and Related Disorders


Sign-up to stay
up-to-date today!


Already registered? Sign In

Original Research

Effect of Zuranolone on Concurrent Anxiety and Insomnia Symptoms in Women With Postpartum Depression

Zuranolone was associated with improvements in depressive and anxiety symptoms and was beneficial for insomnia and patient-perceived...